Aelis Farma (XPAR:AELIS) FCF Margin %: 0.00% (As of Dec. 2025)


XPAR:AELIS Aelis Farma SA XPAR:AELIS
33 GF Score
Price €1.05
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma FCF Margin %?

Aelis Farma XPAR:AELIS -3.49% 33 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates XPAR:AELIS with a GF Score™ of 33/100 and a GF Value™ of €0.98 (Fairly Valued). The stock has 4 warning signs investors should review. Among 954 Biotechnology companies, Aelis Farma ranks worse than 104821.7% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aelis Farma's Free Cash Flow for the six months ended in Dec. 2025 was €-1.47 Mil. Aelis Farma's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Aelis Farma's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Aelis Farma's current FCF Yield % is -37.42%.

The historical rank and industry rank for Aelis Farma's FCF Margin % or its related term are showing as below:


During the past 9 years, the highest FCF Margin % of Aelis Farma was 206.69%. The lowest was -448.88%. And the median was -245.17%.

XPAR:AELIS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.535
* Ranked among companies with meaningful FCF Margin % only.

Aelis Farma FCF Margin % Related Terms

Aelis Farma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Aelis Farma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma FCF Margin % Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only 206.69 -346.23 -144.10 -448.88 0.00

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.56 -373.75 -824.89 0.00 0.00

XPAR:AELIS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Aelis Farma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aelis Farma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Aelis Farma's FCF Margin % falls into.


XPAR:AELIS
33GF Score
Aelis Farma SA XPAR:AELIS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Aelis Farma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.357/0
= %

Aelis Farma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.468/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Aelis Farma (XPAR:AELIS) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aelis Farma and its competitors. According to the industry distribution chart, Aelis Farma ranks #999999 out of 954 companies in the Biotechnology industry.
Is Aelis Farma's FCF Margin % too high?
Aelis Farma's current FCF Margin % is 0.00%. Based on the distribution chart, Aelis Farma ranks #999999 out of 954 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aelis Farma has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aelis Farma ranks #999999 out of 954 companies for FCF Margin %. This places Aelis Farma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aelis Farma and its competitors. Aelis Farma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Based on GuruFocus' analysis, Aelis Farma (XPAR:AELIS) is currently considered Fairly Valued. The stock's GF Value™ is €0.98, compared to a current price of €1.05 — trading 7.1% above its estimated fair value. The current FCF Margin % is 0.00%. Aelis Farma's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aelis Farma (XPAR:AELIS), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.05 is trading 7.1% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • FCF Margin %: 0.00%
  • GF Value™: €0.98 vs. price of €1.05 (7.1% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
33GF Score

Get the complete analysis for XPAR:AELIS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.05
Price
€0.98
GF Value